Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein α subunits

Molecular Pharmacology

Volumn 50, Issue 2, 1996, Pages 293-298

  Standifer, Kelly M ^a,c   Rossi, Grace C ^a   Pasternak, Gavril W ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; OPIATE; PROTEIN SUBUNIT;

ALTERNATIVE RNA SPLICING; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DNA PROBE; DRUG MECHANISM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SPINAL ANESTHESIA; SYMPATHETIC BLOCKING;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; BASE SEQUENCE; GTP-BINDING PROTEINS; MALE; MICE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, OPIOID;

EID: 0029837191     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Pasternak, G. W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1-18 (1993).
2. Pasternak, G. W., and K. M. Standifer. Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol. Sci. 16:344-350 (1995).
3. Uhl, G. R., S. Childers, and G. W. Pasternak. An opiate-receptor gene family reunion. Trends Neurosci. 17:89-93 (1994).
4. Reisine, T., and G. I. Bell. Molecular biology of opioid receptors. Trends Neurosci. 16:506-510 (1993).
5. Standifer, K. M., C.-C. Chien, C. Wahlestedt, G. P. Brown, and G. W. Pasternak. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron 12:805-810 (1994).
6. 3-related opioid receptor using antisense oligodeoxynucleotides. Regul. Pept. 54:217-218 (1994).
7. 3-related opioid receptor. Mol. Pharmacol. 47:1180-1188 (1995).
8. Rossi, G. C., Y.-X. Pan, G. P. Brown, and G. W. Pasternak. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6β-glucuronide receptor. FEBS Lett. 369:192-196 (1995).
9. Chien, C.-C., G. Brown, Y.-X. Pan, and G. W. Pasternak. Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor. Eur. J. Pharmacol. 253:R7-R8 (1994).
10. Adams, J. U., X. Chen, J. K. Deriel, M. W. Adler, and L.-Y. Liu-Chen. Intracerebroventricular treatment with an antisense oligodeoxynucleotide to kappa-opioid receptors inhibited kappa-agonist-induced analgesia in rats. Brain Res. 667:129-132 (1994).
11. Chen, X. H., J. U. Adams, E. B. Geller, J. K. Deriel, M. W. Adler, and L.-Y. Liu-Chen. An antisense oligodeoxynucleotide tb μ-opioid receptors inhibits μ-opioid receptor agonist-induced analgesia in rats. Ear. J. Pharmacol. 276:105-108 (1995).
12. Tseng, L. F., K. A. Collins, and J. P. Kampine. Antisense oligodeoxynucleotide to a δ-opioid receptor selectively blocks the spinal antinociception induced by δ-, but not μ- or κ-opioid receptor agonists in the mouse. Eur. J. Pharmacol. 258:R1-R3 (1994).
13. 4]deltorphin. Regul. Pept. 54:159-160 (1994).
14. 32P]GTP labeling of multiple G protein a subunits. J. Neurochem. 64:2534-2543 (1995).
15. Prather, P. L., H. H. Loh, and P. Y. Law. Interaction of δ-opioid receptors with multiple G proteins: a nonrelationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. Mol. Pharmacol. 45: 997-1003 (1994).
16. Prather, P. L., T. M. McGinn, L. J. Erickson, C. J. Evans, H. H. Loh, and P.-Y. Law. Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density. J. Biol. Chem. 269:21293-21302 (1994).
17. α subunit and is similar to that of other opioid receptors. Mol. Brain Res. 29:336-346 (1995).
18. Roerig, S. C., H. H. Loh, and P. Y. Law. Identification of three separate guanine nucleotide-binding proteins that interact with the δ-opioid receptor in NG108-15 neuroblastoma X glioma hybrid cells. Mol. Pharmacol. 41:822-831 (1992).
19. i2 protein a subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma X dorsal root ganglion hybrid cells. Mol. Pharmacol. 48: 189-193 (1995).
20. Raffa, R. B., R. P. Martinez, and C. D. Connelly. G-protein antisense oligodeoxyribonucleotides and μ-opioid supraspinal antinociception. Eur J. Pharmacol. 258:R5-R7 (1994).
21. i3 transducer proteins. Life Sci. 53:PL129-PL134 (1993).
22. i2 transducer proteins on μ/δ opioid mediate supraspinal antinociception. Life Sci. 53:PL381-PL386 (1993).
23. sα enhances the supraspinal antinotiception induced by morphine, β-endorphin and clonidine in mice. Life Sci. 51: PL237-PL242 (1992).
24. i2 transducer proteins. Life Sci. 55:PL205-PL212 (1995).
25. i2α antisense oligonucleotide differentiates morphine antinociception, constipation and acute dependence in mice. Life Sci. 5:PL73-PL76 (1996).
26. Sanchez-Blazquez, P., A. Garcia-Espana, and J. Garzon. In vivo injection of antisense oligodeoxynucleotides to Gα subunits and supraspinal analgesia evoked by mu and delta opioid agonists. J. Pharmacol. Exp. Ther. 275:1590-1596 (1995).
27. Luke, M. C., E. F. Hahn, M. Price, and G. W. Pasternak. Irreversible opiate agonists and antagonists. V. Hydrazone and acylhydrazone derivatives of naltrexone. Life Sci. 43:1249-1256 (1988).
28. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
29. Haley, T. J., and W. G. McCormick. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12:12-15 (1957).
30. Hylden, J. L. K., and G. L. Wilcox. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:313-316 (1980).
31. D'Amour, F. E., and D. L. Smith. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:174-179 (1941).
32. Paul, D., K. M. Standifer, C. E. Inturrisi, and G. W. Pasternak. Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Ther. 251:477-483 (1989).
33. Rossi, G. C., G. W. Pasternak, and R. J. Bodnar. Synergistic brainstem interactions for morphine analgesia. Brain Res. 624:171-180 (1993).
34. Rossi, G. C., K. M. Standifer, and G. W. Pasternak. Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein α subunits in rats. Neurosci. Lett. 198:99-102 (1995).
35. O. Mol. Pharmacol. 44:62-69 (1993).
36. O mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain. Proc. Natl. Acad. Sci. USA 90:2061-4066 (1993).
37. Laugwitz, K. L., S. Offermanns, K. Spicher, and G. Schultz. μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma cells. Neuron 10:233-242 (1993).
38. i in Xenopus oocytes. FEBS Lett. 333:311-314 (1993).
39. 3 cells. Mol. Pharmacol. 47:1041-1049 (1995).
40. Misawa, H., H. Ueda, T. Katada, M. Ui, and M. Satoh. A subtype of opioid kappa-receptor is coupled to inhibition of Gi1-mediated phospholipase C activity in the guinea pig cerebellum. FEBS Lett. 361:106-110 (1995).
41. Tsu, R. C., J. S. C. Chan, and Y. H. Wong. Regulation of multiple effectors by the cloned δ-opioid receptor: stimulation of phospholipase C and type II adenylyl cyclase. J. Neurochem. 64:2700-2707 (1995).
42. z coupling to the rat kappa-opioid receptor. FEBS Lett. 360:97-99 (1995).
43. Bodnar, R. J., D. Paul, M. Rosenblum, L. Liu, and G. W. Pasternak. Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus. Brain Res. 529:324-328 (1990).